Shifting the treatment paradigm for patients with deficient mismatch repair colon cancer: is there a role for immunotherapy?

ANZ J Surg. 2021 May;91(5):778-780. doi: 10.1111/ans.16485.

Authors

Joseph C Kong^{1

2

3}, Michael Flood^{1

2

3}, Robert G Ramsay^{2

3}, Satish K Warrier^{1

2

3}, Alexander Heriot^{1

2

3}

Affiliations

¹ Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
² Division of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
³ Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.

PMID: 33999535
DOI: 10.1111/ans.16485

No abstract available

MeSH terms

Colonic Neoplasms* / therapy
Colorectal Neoplasms*
DNA Mismatch Repair / genetics
Humans
Immunotherapy